Drug Discovery and Medicinal Chemistry
The main focus of our research is the application of computer-aided drug design and synthetic chemistry to create new drug candidates for cancer, viral infections, and neurodegenerative diseases such as Alzheimer’s disease. Novel molecules are evaluated using a variety of biochemical, biophysical, and cell-based screening assays, as well as animal models of disease, both within our lab and in partnership with local and international collaborators. Consideration of drug-likeness is an integral part of our design process, since good ADMET properties are crucial for our molecules to reach the clinic.
Please note:Many of our projects are commercially sensitive and cannot be advertised on the web. Please contact Dr Ben Ross to discuss the Group's latest research projects.
2 April 2013: Welcome Mr Suresh Veliyath (PhD candidate). Suresh has a masters degree in pharmaceutical chemistry from Rajiv Gandhi University, Bangalore. He worked as a project assistant at the Indian Institute of Science (IISC) Bangalore and as a faculty member at MIPS Hyderabad, before joining the Ross Group. Suresh's PhD project is focused on AD drug discovery.
6 February 2013: Welcome Mr Girdhar Singh Deora (PhD candidate). Giri completed a MPharm from Rajiv Gandhi Technological University, Bhopal in 2009. Prior to joining the Ross Group, Giri worked as a research associate at Rajiv Gandhi Technological University (2010-11) and at Dr Reddy's Institute of Life Sciences, Hyderabad (2011-13). Giri's PhD project is in the field of AD drug discovery.
10 January 2013: Welcome Mr Edward Lee (PhD candidate). Eddy completed a BPharm (2010) and postgraduate honours (2012) degrees at UQ and he was awarded an APA scholarship for his PhD project to develop anti-viral nanoparticles.
1 November 2012: Welcome Mr Satish Dighe (PhD candidate). Satish was awarded an MPharm in 2009 from Pune University, and worked as a research chemist at Zydus-Cadila Healthcare Limited (2009-11; Ahmedabad) and as a research assistant at the Birla Institute of Techology and Science (2011-12; Pilani), before joining the Ross Group. The topic of Satish's PhD project is AD drug discovery.
3 July 2012: Welcome Mr Srinivas Kantham (PhD candidate) who is funded by a prestigious Prime Minister's Australia Asia Incoming Postgraduate Award. For his PhD Srinivas is developing polyphenols as disease-modifying drugs for AD. Previously he worked as a research assistant at the Indian Institute of Chemical Technology (IICT) Hyderabad.
Dr Ben Ross
School of Pharmacy,
The University of Queensland,
20 Cornwall Street,
Woolloongabba, Qld 4102,
School of Pharmacy,
The University of Queensland, Brisbane, Qld 4072, Australia
Phone: +61 7 334 61900
Fax: +61 7 334 61999
This web site was last updated on 16 December 2015. Copyright © 2006-2016 Benjamin P. Ross. Unless stated otherwise, this web site represents only the views of Benjamin P. Ross and not the views of The University of Queensland. Simple site map.